Downregulation of TDP43 by atovaquone inhibits oxidative phosphorylation and enhances sensitivity of triple-negative breast cancer to EGFR-TKIs.

Saved in:
Bibliographic Details
Title: Downregulation of TDP43 by atovaquone inhibits oxidative phosphorylation and enhances sensitivity of triple-negative breast cancer to EGFR-TKIs.
Authors: Lin, Liang1 (AUTHOR), Ke, Hao1,2 (AUTHOR) kehao@jxsfybjy2.wecom.work, Chen, Mengxin1 (AUTHOR), Zhang, Yi1,3,4 (AUTHOR), Fu, Shiting5 (AUTHOR), Yu, Fan1 (AUTHOR), Su, Jianbin1 (AUTHOR), Yang, Xing4 (AUTHOR), Guo, Yingqi6 (AUTHOR), Ding, Qianzhe1 (AUTHOR), Zhang, Yuhan1 (AUTHOR), Zhao, Limin1 (AUTHOR) zhaolimin@ncu.edu.cn
Source: Free Radical Biology & Medicine. Jul2026, Vol. 250, p64-79. 16p.
Database: Academic Search Ultimate
Description
ISSN:08915849
DOI:10.1016/j.freeradbiomed.2026.03.047